Largest health care companies by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Johnson & Johnson leads the 170 health care companies ranked by earnings, at SGD 34.6B, ahead of Eli Lilly (SGD 26.6B) and Merck & Co (SGD 23.6B). Figures as of 19 Nov 2026, 15:28 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 170
- First
- Johnson & JohnsonSGD 34.6B
- Median
- SGD 351.3M
- Combined market value
- SGD 11.62T
- Countries
- 14
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 101 | Hims & Hers HealthHIMS · Health Care | SGD 165.7M | SGD 5B | SGD 21.23 | 3.55% down | 49% down | ||
| 102 | Ligand PharmaceuticalsLGND · Health Care | SGD 160.7M | SGD 7.6B | SGD 381.84 | 0.99% down | 50% up | ||
| 103 | Corcept TherapeuticsCORT · Health Care | SGD 128.7M | SGD 9.4B | SGD 85.97 | 1.77% down | 10% down | ||
| 104 | HaemoneticsHAE · Health Care | SGD 125.6M | SGD 7.2B | SGD 157.48 | 0.72% down | 64% up | ||
| 105 | Amneal PharmaceuticalsAMRX · Health Care | SGD 93M | SGD 9.7B | SGD 27.96 | 1.01% down | 90% up | ||
| 106 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SGD 76.2M | SGD 9.6B | SGD 122.31 | 0.33% down | 129% up | ||
| 107 | RepligenRGEN · Health Care | SGD 63.1M | SGD 14.6B | SGD 227.65 | 2.12% up | 12% up | ||
| 108 | LifeStance Health GroupLFST · Health Care | SGD 12.5M | SGD 6.6B | SGD 17.35 | 2.40% down | 123% up | ||
| 109 | BillionToOneBLLN · Health Care | SGD 9.6M | SGD 5.6B | SGD 117.68 | 0.43% down | 4% down | ||
| 110 | Arrowhead PharmaceuticalsARWR · Health Care | -SGD 2.1M | SGD 8.1B | SGD 57.42 | 3.17% up | 13% up | ||
| 111 | BrukerBRKR · Health Care | -SGD 11.1M | SGD 12.8B | SGD 83.82 | 2.63% up | 44% up | ||
| 112 | RadNetRDNT · Health Care | -SGD 24.1M | SGD 7.2B | SGD 90.96 | 1.90% down | 9% down | ||
| 113 | Mirum PharmaceuticalsMIRM · Health Care | -SGD 30.2M | SGD 7.9B | SGD 121.06 | 1.38% up | 34% up | ||
| 114 | Travere TherapeuticsTVTX · Health Care | -SGD 33M | SGD 6.2B | SGD 64.90 | 0.06% up | 45% up | ||
| 115 | 10x GenomicsTXG · Health Care | -SGD 56.2M | SGD 10.3B | SGD 78.05 | 5.92% up | 247% up | ||
| 116 | Adaptive BiotechnologiesADPT · Health Care | -SGD 76.8M | SGD 6B | SGD 37.32 | 1.58% up | 74% up | ||
| 117 | Caris Life SciencesCAI · Health Care | -SGD 87.9M | SGD 7.3B | SGD 25.60 | 1.69% up | 19% down | ||
| 118 | VeradermicsMANE · Health Care | -SGD 90.4M | SGD 6.9B | SGD 163.05 | 1.14% up | 231% up | ||
| 119 | Belite BioBLTE · Health Care | -SGD 100.2M | SGD 8.1B | SGD 199.48 | 1.10% down | 43% up | ||
| 120 | Twist BioscienceTWST · Health Care | -SGD 100.3M | SGD 10.6B | SGD 155.50 | 3.52% up | 346% up | ||
| 121 | Oruka TherapeuticsORKA · Health Care | -SGD 136.1M | SGD 8.7B | SGD 128.54 | 3.99% up | 255% up | ||
| 122 | HeartflowHTFL · Health Care | -SGD 150.8M | SGD 5.2B | SGD 58.60 | 1.09% down | 66% up | ||
| 123 | ErascaERAS · Health Care | -SGD 160.8M | SGD 6.4B | SGD 18.32 | 3.12% up | 395% up | ||
| 124 | Protagonist TherapeuticsPTGX · Health Care | -SGD 168M | SGD 10.8B | SGD 165.33 | 0.70% up | 51% up | ||
| 125 | Charles River Laboratories InternationalCRL · Health Care | -SGD 186.4M | SGD 20.8B | SGD 434.86 | 1.07% up | 106% up | ||
| 126 | Spyre TherapeuticsSYRE · Health Care | -SGD 200.4M | SGD 12.2B | SGD 128.42 | 1.96% down | 332% up | ||
| 127 | CG OncologyCGON · Health Care | -SGD 207.9M | SGD 9.6B | SGD 107.24 | 3.83% up | 97% up | ||
| 128 | Dianthus TherapeuticsDNTH · Health Care | -SGD 209.6M | SGD 6.3B | SGD 111.16 | 2.52% up | 108% up | ||
| 129 | Edgewise TherapeuticsEWTX · Health Care | -SGD 216.6M | SGD 5.8B | SGD 53.06 | 0.65% down | 86% up | ||
| 130 | Axsome TherapeuticsAXSM · Health Care | -SGD 236.5M | SGD 9.1B | SGD 173.67 | 0.39% up | 6% down | ||
| 131 | Definium TherapeuticsDFTX · Health Care | -SGD 237.3M | SGD 5.1B | SGD 37.51 | 0.24% down | 168% up | ||
| 132 | GlaukosGKOS · Health Care | -SGD 242.3M | SGD 18.1B | SGD 305.61 | 1.56% up | 145% up | ||
| 133 | Rhythm PharmaceuticalsRYTM · Health Care | -SGD 253.7M | SGD 10.6B | SGD 153.16 | 0.34% down | 18% up | ||
| 134 | NateraNTRA · Health Care | -SGD 268.7M | SGD 57B | SGD 393.13 | 5.18% up | 28% up | ||
| 135 | Kodiak SciencesKOD · Health Care | -SGD 296.9M | SGD 8.2B | SGD 125.35 | 0.74% down | 399% up | ||
| 136 | Elanco Animal HealthELAN · Health Care | -SGD 299.5M | SGD 17.3B | SGD 34.52 | 0.15% up | 26% up | ||
| 137 | LivaNovaLIVN · Health Care | -SGD 313M | SGD 6.6B | SGD 119.30 | 2.26% down | 77% up | ||
| 138 | Ascendis PharmaASND · Health Care | -SGD 326.6M | SGD 22.8B | SGD 347.35 | 0.48% down | 29% up | ||
| 139 | Madrigal PharmaceuticalsMDGL · Health Care | -SGD 372.2M | SGD 12B | SGD 517.27 | 0.65% up | 27% down | ||
| 140 | Legend BiotechLEGN · Health Care | -SGD 383.2M | SGD 4B | SGD 20.50 | 2.28% down | 41% down | ||
| 141 | Roivant SciencesROIV · Health Care | -SGD 387M | SGD 37B | SGD 51.01 | 2.01% up | 91% up | ||
| 142 | Praxis Precision MedicinesPRAX · Health Care | -SGD 391.5M | SGD 11.5B | SGD 411.41 | 4.41% up | 86% up | ||
| 143 | Kymera TherapeuticsKYMR · Health Care | -SGD 402M | SGD 13.3B | SGD 156.10 | 0.18% down | 87% up | ||
| 144 | Cogent BiosciencesCOGT · Health Care | -SGD 424.7M | SGD 6.4B | SGD 36.63 | 2.03% up | 20% down | ||
| 145 | MiniMed GroupMMED · Health Care | -SGD 429.9M | SGD 6B | SGD 21.23 | 3.24% down | 8% down | ||
| 146 | ImmunityBioIBRX · Health Care | -SGD 453.7M | SGD 9.1B | SGD 8.51 | 1.64% down | 232% up | ||
| 147 | Jazz PharmaceuticalsJAZZ · Health Care | -SGD 459.8M | SGD 20.1B | SGD 313.16 | 2.10% down | 41% up | ||
| 148 | Bausch + LombBLCO · Health Care | -SGD 464.8M | SGD 9.6B | SGD 26.96 | 0.33% down | 44% up | ||
| 149 | ABIVAXABVX · Health Care | -SGD 481.5M | SGD 9.7B | SGD 110.39 | 1.99% up | 32% down | ||
| 150 | Scholar Rock HoldingSRRK · Health Care | -SGD 487.9M | SGD 7.8B | SGD 64.13 | 3.48% up | 26% up | ||
| 151 | Ionis PharmaceuticalsIONS · Health Care | -SGD 492.4M | SGD 5.9B | SGD 35.49 | 0.35% up | 63% down | ||
| 152 | GRAILGRAL · Health Care | -SGD 527.2M | SGD 6.4B | SGD 142.04 | 7.76% up | 19% up | ||
| 153 | Guardant HealthGH · Health Care | -SGD 537.4M | SGD 26.7B | SGD 197.02 | 5.14% up | 45% up | ||
| 154 | Oscar HealthOSCR · Health Care | -SGD 572.1M | SGD 10.7B | SGD 34.54 | 2.97% down | 112% up | ||
| 155 | ImmunovantIMVT · Health Care | -SGD 652.8M | SGD 8.9B | SGD 42.98 | 0.36% up | 46% up | ||
| 156 | AvantorAVTR · Health Care | -SGD 684.5M | SGD 13.5B | SGD 19.85 | 0.03% up | 40% up | ||
| 157 | CRISPR TherapeuticsCRSP · Health Care | -SGD 750.9M | SGD 5.1B | SGD 52.87 | 1.89% up | 18% down | ||
| 158 | BridgeBio PharmaBBIO · Health Care | -SGD 946.3M | SGD 19.9B | SGD 102.14 | 1.41% up | 21% up | ||
| 159 | VaxcytePCVX · Health Care | -SGD 989.8M | SGD 12.3B | SGD 77.50 | 2.58% up | 23% up | ||
| 160 | CytokineticsCYTK · Health Care | -SGD 1B | SGD 9.3B | SGD 66.93 | 1.02% up | 19% down | ||
| 161 | TeleflexTFX · Health Care | -SGD 1.2B | SGD 8.5B | SGD 214.05 | 0.03% down | 58% up | ||
| 162 | Takeda PharmaceuticalTAK · Health Care | -SGD 1.2B | SGD 88.6B | SGD 27.73 | 1.00% up | 51% up | ||
| 163 | Baxter InternationalBAX · Health Care | -SGD 1.2B | SGD 17.1B | SGD 33.06 | 2.10% down | 50% up | ||
| 164 | Summit TherapeuticsSMMT · Health Care | -SGD 1.4B | SGD 11B | SGD 13.73 | 1.29% up | 36% down | ||
| 165 | Revolution MedicinesRVMD · Health Care | -SGD 1.5B | SGD 45.8B | SGD 211.54 | 2.52% up | 129% up | ||
| 166 | BioNTechBNTX · Health Care | -SGD 1.6B | SGD 26.4B | SGD 106.50 | 0.92% down | 14% down | ||
| 167 | InsmedINSM · Health Care | -SGD 1.6B | SGD 39.7B | SGD 180.92 | 16.97% up | 40% down | ||
| 168 | ModernaMRNA · Health Care | -SGD 3.6B | SGD 102.1B | SGD 252.26 | 0.71% down | 780% up | ||
| 169 | ViatrisVTRS · Health Care | -SGD 4.5B | SGD 29.7B | SGD 25.88 | 1.16% down | 99% up | ||
| 170 | CenteneCNC · Health Care | -SGD 8.6B | SGD 41.7B | SGD 84.20 | 3.31% down | 94% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2911 SGD).
Questions and answers
Which health care companies rank first by earnings?
Johnson & Johnson (SGD 34.6B), Eli Lilly (SGD 26.6B) and Merck & Co (SGD 23.6B) are the top three of the 170 health care companies ranked by earnings as of 19 Nov 2026, 15:28 UTC.
How many health care companies are in this ranking?
170 are ranked by earnings.
What are these health care companies worth together?
The 170 health care companies ranked by earnings have a combined market value of SGD 11.62T as of 19 Nov 2026, 15:28 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest health care companies by earnings”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.